Letter to the Editor: In response to PR Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy-MedSci.cn

Letter to the Editor: In response to PR Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy

Muntoni, F; Straub, V; Servais, L; Mercuri, E

Muntoni, F (通讯作者)，UCL, Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.;Muntoni, F (通讯作者)，UCL, Great Ormond St Inst Child Hlth, MRC Ctr Neuromuscular Dis, London, England.;Muntoni, F (通讯作者)，Great Ormond St Hosp Children Fdn Trust, London, England.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Letter to the Editor: In response to PR Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy

科室

工具

服务